Hesperidin



Compound IDCDAMM00551
Common nameHesperidin
IUPAC name5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
Molecular formulaC28H34O15

Experimental data

Retention time12.75
Adduct[M+H]+
Actual mz611.198
Theoretical mz611.197
Error1.35
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2543

Identifiers and class information

Inchi keyQUQPHWDTPGMPEX-SHXQGXTJNA-N
SmilesO=C1C2=C(O)C=C(OC3OC(COC4OC(C)C(O)C(O)C4O)C(O)C(O)C3O)C=C2OC(C5=CC=C(OC)C(O)=C5)C1
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)14
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)610.568
Computed dipole moment(dipole)6.021
Total solvent accessible surface area (SASA)874.459
Hydrophobic component of SASA (FOSA)384.357
Hydrophilic component of SASA (FISA)334.836
Pie component of the SASA (PISA)155.266
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1661.64
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)20.05
Free energy of solvation of dipole (dip^2/V)0.021814
Index of cohesive interaction in solids (ACxDN^.5/SA)0.060663
Globularity descriptor (glob)0.775859
Predicted polarizability in cubic angstroms (QPpolrz)52.838
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.822
Predicted octanol/gas partition coefficient (QPlogPoct)39.477
Predicted water/gas partition coefficient (QPlogPw)32.07
Predicted octanol/water partition coefficient (QPlogPo/w)-1.173
Predicted aqueous solubility (QPlogS)-3.263
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.33
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.899
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)6.617
Predicted brain/blood partition coefficient (QPlogBB)-3.989
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2.181
Predicted skin permeability, log Kp (QPlogKp)-5.799
PM3 calculated ionization potential (IP(ev))8.91
PM3 calculated electron affinity (EA(eV))0.073
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-1.178
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)238.223
Number of nitrogen and oxygen atoms (#NandO)15
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P11511CYP19A1Cytochrome P450 19A1T13260SwissTargetPrediction and SEA
P20151KLK2Kallikrein 2T01908SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025